Contact Us
Home » Page 4

news20_42nd Annual_January 5, 2024_1523x510
Events, Investors

42nd Annual J.P. Morgan Healthcare Conference

Bora Pharmaceuticals has been invited to participate in the prestigious

news21_Bora Pharmaceuticals_December 11, 2023_1523x510
Business

Bora Pharmaceuticals Celebrates Integration with SunWay Biotech, Embarking on a Global Journey

Taipei, Taiwan - December 11, 2023 – Last Friday, Bora
news13_Bora Recognized_December 8, 2023_1523x510
Business

Bora Recognized at “2023 Most Outstanding Company of the Year Awards.” Ceremony Attended by President Tsai Ing-wen

Bora Pharmaceuticals honored at the "2023 Most Outstanding Company of
BioJapan 2023
Events

Bio Japan 2023

Bio Japan 2023 Meet with Bora at Bio Japan October

Taoyuan unveiling
Business

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in
news28_Bora Pharmaceuticals_July 28, 2023_1523x510
Business

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at

cphi social
Events

CPhI Barcelona 2023

CPhI Barcelona 2023 Meet with Bora at CPhI October 24-26,

contractpharma social
Events

22nd Annual Contracting & Outsourcing Conference

22nd Annual Contracting & Outsourcing Conference Meet with Bora at

9dab371d8d3507a5ed312a0f45bcb7dc
Business

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in
image-missing
Business

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Establishing a lead position in Taiwan's CDMO sector
news26_Bora Pharmaceuticals_May 10, 2022_1523x510
Business

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market

Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora

news26_Bora Pharmaceuticals_April 20, 2022_1523x510
Business

Bora Pharmaceuticals to expand operations with $10m investment

TAIWAN – Fast-growing contract development and manufacturing organization (CDMO) BORA

You're leaving our site

You are being redirected to BoraBiologics.com
Cancel